Navigation Links
DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients
Date:10/11/2010

CLEVELAND, Oct. 11 /PRNewswire/ -- The preeminent law office of Nurenberg, Paris, Heller & McCarthy has filed a class action lawsuit against Johnson & Johnson's artificial joint replacement company DePuy Orthopaedics, Inc., on behalf of clients who suffered damages resulting from the company's now-recalled hip replacement device.  (Case No. 1:10CV02222, U.S. District Court, Northern District of Ohio, Eastern Division)

"Revision" Surgeries RequiredDePuy recently recalled two hip replacement products -- the ASR Hip Resurfacing System and the ASR XL Acetabular System -- after data showed that within five years, one in eight patients needed "revision surgeries," which are required when an artificial joint doesn't properly fit or breaks down prematurely. About 93,000 people around the world have received one of these potentially faulty hip implants.

The legal professionals at Nurenberg, Paris, Heller & McCarthy expect the class action lawsuit to include hundreds, if not thousands, of victims. Headed by attorney David M. Paris, the lawsuit is seeking to assist those who have received a DePuy ASR hip implant and experienced pain, had problems walking, or needed a revision surgery to fix a faulty hip implant.

"We're working to get the victims of faulty DePuy hip implants the help they need," said Paris, partner at Nurenberg, Paris, Heller & McCarthy. "The rights, remedies, and needs of each victim are unique and require special attention. As a result, we're conducting a full-scale investigation and have assembled a team of physicians, nurses, and other experts who will be working on behalf of the victims of this disastrous medical device."

Hip Replacement Patients Deceived about CostsThe claim states that DePuy required patients to release their confidential medical records to even be considered for reimbursement of medical costs. As a result, some patients may have been misled into believing DePuy had actually agreed to advance or reimburse costs for medical monitoring and revision procedures when, in fact, DePuy's intent was only to use the medical information to determine if any costs should be reimbursed to patients. Furthermore, these medical releases allow DePuy to gain access to the removed hip replacement devices for testing purposes while denying the test results from the respective patients and their own healthcare experts. Consequently, crucial evidence is prevented from reaching those affected by the defective products.

DePuy Class Action InvolvementNurenberg, Paris, Heller & McCarthy is currently accepting cases on behalf of those who have been affected by the DePuy hip replacement recall and resulting medical issues. Class members involved in this claim may be entitled to the following:

  • payment and/or reimbursement for revision surgeries
  • economic and non-economic damages
  • medical monitoring procedures by caregivers, which include radiographic evaluation, blood testing for cobalt and chromium ion levels, and MRI or ultrasound examinations
  • an injunction to prohibit DePuy from communicating with plaintiffs and class members through their physicians

  • To learn more about DePuy's recall of its ASR Hip Resurfacing System and ASR XL Acetabular System, call Nurenberg, Paris, Heller & McCarthy at (800) 562-7438 or visit www.nphm.com.

    About Nurenberg, Paris, Heller & McCarthyNurenberg, Paris, Heller & McCarthy is a nationally recognized law office that has served the needs of catastrophically injured clients throughout the United States since 1928. Nurenberg Paris is a Cleveland, Ohio-based law firm known for its success in cases involving defective products, class action litigation, medical malpractice, wrongful death, airplane crashes, railroad crossing collisions, unfair business practices, and insurance. The trial lawyers at Nurenberg Paris have been admitted to practice law in courts across the country and pride themselves on their long-standing history of achieving justice for clients in the trial and appellate courts. For more information, visit www.nphm.com.  For more information, contact:Tamara BriningerPhone: (216) 694-5204E-mail: TBrininger@nphm.com
    '/>"/>

    SOURCE Nurenberg, Paris, Heller & McCarthy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
    2. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
    3. DePuy Orthopaedics Voluntarily Recalls ASR™ Hip System
    4. Materialise Launches SurgiCase(R) Orthopaedics: A Comprehensive, Custom Solution That Assures Best Practices For The Orthopaedic Surgeon
    5. Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System
    6. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
    7. Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries
    8. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
    9. Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
    10. Clinical Trial Establishes Catheter-Based Aortic Valve Replacement as New Standard of Care for Patients Who Cannot Undergo Surgery
    11. Patients Should Expect Long Life from their Joint Replacements!
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/2/2017)... , Aug. 2, 2017 Fenita ... Who as a Pinnacle Lifetime Professional in the ... Account Manager at Turing Pharmaceuticals, AG. Her skills ... and relationship building.                ... than 25 years of experience as a highly ...
    (Date:8/2/2017)... , Aug. 2, 2017  Life Flight Network and PeaceHealth ... agreement improves patient care and operational efficiency for patients at ... , Cottage Grove , and ... transportation. PeaceHealth and Life Flight Network work collaboratively to move ... transport, or when a time sensitive emergency exists. ...
    (Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
    Breaking Medicine Technology:
    (Date:8/23/2017)... ... August 23, 2017 , ... CEFEX, the Centre ... to the standards representing best practices in the retirement plan industry. The independent ... and helps to verify that NFP’s retirement division focuses on putting clients’ interests ...
    (Date:8/23/2017)... Mesa, Arizona (PRWEB) , ... August 23, 2017 ... ... is in the top 20% of hospitals nationally that earned the designation of ... annual list. An overall rating of high performing indicates a hospital was significantly better ...
    (Date:8/23/2017)... ... August 23, 2017 , ... TSC ... Awards® - for Risk Management Solution Innovations and Security Solution for Government Innovations. ... released in 2017 and its DHS SAFETY Act-designated enterprise security assessment approach. , ...
    (Date:8/22/2017)... ... August 22, 2017 , ... The ... health is as simple as eating healthy foods. But this well-known piece of ... making insulin, or breaking apart carbohydrates—depends not only on properties of the food ...
    (Date:8/22/2017)... ... ... Nurses at Apple Rehab Watch Hill , a nursing and rehabilitation ... in Closed Pulse Irrigation™ (CPI) for wound care. This qualifies Apple ... Medicare and Medicaid Services, to have a CPI machine that will provide better quality ...
    Breaking Medicine News(10 mins):